Prudential Financial Inc Harvard Bioscience Inc Transaction History

Prudential Financial Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$2.77 - $4.63 $31,578 - $52,782	-11,400 Reduced 15.65%	61,460 $175,000
Q1 2024 May 14, 2024	SELL	$4.02 - $5.39 $67,134 - $90,013	-16,700 Reduced 18.65%	72,860 $308,000
Q4 2023 Feb 13, 2024	SELL	$4.0 - $5.49 $16,000 - $21,960	-4,000 Reduced 4.28%	89,560 $479,000
Q3 2023 Nov 13, 2023	BUY	$4.0 - $5.82 $312,400 - $454,542	78,100 Added 505.17%	93,560 $402,000
Q2 2023 Aug 11, 2023	BUY	$4.19 - $6.16 $64,777 - $95,233	15,460 New	15,460 $84,000
Q2 2022 Aug 15, 2022	BUY	$3.28 - $6.42 $33,456 - $65,484	10,200 New	10,200 $37,000
Q4 2021 Feb 14, 2022	SELL	$6.37 - $8.18 $83,669 - $107,444	-13,135 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$6.98 - $8.47 $2,610 - $3,167	-374 Reduced 2.77%	13,135 $92,000
Q2 2021 Aug 16, 2021	BUY	$5.44 - $8.4 $73,488 - $113,475	13,509 New	13,509 $113,000

31.5M

700

2.1K

Ticker HBIO
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 41,636,500
Market Cap $90.4M
Description
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Prudential Financial Inc with notifications on news.